Bagsvaerd, Denmark-based Novo Nordisk A/S' board of directors proposed the election of Andreas Fibig and Martin Mackay as board members.
Fibig is the CEO and chairman of International Flavors & Fragrances Inc., while Mackay was formerly the executive vice president and global head of research and development at Alexion Pharmaceuticals Inc.
Both appointments will be proposed at the drugmaker's annual meeting in March.
